Integrated test injection deviceTechnical Field
The utility model belongs to the technical field of insulin injection device and blood sugar test equipment, especially, relate to an integral type test injection device.
Background
Diabetes is a common, non-infectious, chronic disease that seriously compromises human health, and an important means for delaying diabetes and its complications is to frequently measure the blood glucose concentration of a patient. Diabetic patients traditionally need to monitor their daily blood glucose levels by measuring the blood taken from their fingertips using a conventional testing instrument, which is an uncomfortable pain and high risk of infection, a source of concern.
Most of the instruments for patient feedback, blood sugar test and injection are troublesome to use and operate, and the regular measurement and injection can be realized only at home; when the device is used for playing or working outside, the timing measurement cannot be carried out due to troublesome operation. For the condition of going out, the fact that many patients can not measure regularly often causes serious consequences, leads to the fact that the patient needs to go to hospital in time to treat.
Therefore, there is a need to develop an integrated test injection device that is convenient for the patient to use.
SUMMERY OF THE UTILITY MODEL
In order to solve the problem that current blood sugar test instrument and injection insulin are not convenient, the utility model provides an integral type test injection device.
Compared with the prior art, the utility model innovation part lies in:
the utility model discloses integral type test injection device, including casing and fixed disk, injection subassembly and the test subassembly of locating in it, the injection subassembly is fixed in on the fixed disk, the injection subassembly side is located to the test subassembly, carries out the insulin injection to the human body through the injection subassembly, and the test subassembly carries out the blood sugar test to the human body.
Further, the injection assembly comprises a power tube, a storage tube and a needle head piece, the storage tube is installed below the power tube, the needle head piece is connected with the storage tube, insulin is filled in the storage tube, and the insulin is injected through the power tube and the needle head piece.
Furthermore, the test component comprises a microprocessor, an infrared emission laser, a detector, a signal regulating circuit and a display screen, wherein the infrared emission laser, the detector, the signal regulating circuit and the display screen are electrically connected with the microprocessor, the infrared emission laser irradiates the skin of the human body and transmits signals to the detector, the detector converts optical signals into electric signals and transmits the electric signals to the signal regulating circuit for amplification, filtering and shaping, and the microprocessor performs correlation operation on the blood glucose concentration of the human body and transmits the blood glucose concentration result of the human body to the display screen.
Furthermore, the casing is including first cavity and second cavity, injection subassembly and fixed disk have been placed to first cavity, test assembly has been placed to the second cavity.
Furthermore, the first cavity comprises an upper cavity and a lower cavity, the power tube is placed in the upper cavity, the storage tube and the needle piece are placed in the lower cavity, and the fixed disc is clamped between the upper cavity and the lower cavity.
Furthermore, the lower cavity comprises a pushing cover and a clamping position, the pushing cover is detachably mounted on the clamping position, and the storage tube is mounted in the lower cavity by detaching the pushing cover.
Furthermore, the upper chamber includes spout and slide button, the slide button is connected the power tube and is located in the spout, slides along the spout through the slide button and promotes the power tube.
Furthermore, a display window and a key are arranged on the second cavity, a display screen is arranged below the display window, the key is electrically connected with the infrared emission laser, and the blood glucose concentration is watched through the display window and the key controls the infrared emission laser to work.
Further, the power tube comprises a top, a piston rod and a push key, the top and the push key are respectively arranged at two ends of the piston rod, the push key is fixedly connected with the slide button, and the push key pushes the top at the other end of the piston rod to slide under the movement of the slide button, so that the injection action is performed.
Further, the storage tube is including the pipe support and locate rubber film, body and the piston in it, the both ends of body are located to rubber film and piston, rubber film is connected with syringe needle spare, the piston is connected with the top of power pipe, the filling has insulin in the body, be equipped with the scale on the pipe support, through observing the volume of scale control injection insulin.
The beneficial effects of the utility model reside in that:
(1) the blood glucose tester and the insulin injector are integrated, so that the blood glucose tester is convenient and easy to carry, and the problems of untimely blood glucose measurement and insulin injection of a patient due to troublesome use are solved;
(2) the test component adopts a non-invasive blood glucose test, adopts an infrared emission laser and a detector to test the blood glucose concentration of a human body in a combined manner, and does not have pain and infection risks;
(3) the injection assembly is designed by matching with the shell, the storage tube can be installed by opening the detachable push cover, and the injection of the insulin is pushed through the chute and the sliding button of the upper cavity, so that the convenience and the rapidness are realized;
(4) the shell is provided with a window for displaying the blood sugar concentration and a scale window for the insulin allowance, thereby facilitating the user to control the amount of the injected insulin.
Drawings
Fig. 1 is a schematic view of the overall structure of the integrated test injection device of the present invention;
FIG. 2 is a schematic view of an injection assembly of the integrated test injection apparatus of the present invention;
FIG. 3 is a schematic structural view of a testing assembly of the integrated test injection device of the present invention;
FIG. 4 is a first exploded view of the integrated test injection device of the present invention with the top thereof not reaching the bottom;
FIG. 5 is a second exploded view of the integrated test injection device of the present invention with the top thereof not reaching the bottom;
fig. 6 is a schematic block diagram of a testing assembly of the integrated test injection device of the present invention.
In the figure, 1 is a housing, 11 is a first cavity, 111 is an upper cavity, 1111 is a sliding slot, 1112 is a sliding button, 112 is a lower cavity, 1121 is a push cover, 1122 is a clip, 12 is a second cavity, 121 is a display window, 122 is a button, 2 is a fixed disk, 3 is an injection component, 31 is a power tube, 311 is a top, 312 is a piston rod, 313 is a push button, 32 is a storage tube, 321 is a tube frame, 3211 is a scale, 322 is a rubber film, 323 is a tube body, 324 is a piston, 33 is a needle piece, 331 is a needle, 3312 is a needle cap, 4 is a test component, 41 is a microprocessor, 42 is an infrared emission laser, 43 is a detector, 44 is a signal conditioning circuit, and 45 is a display screen.
Detailed Description
The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings of the present invention.
Referring to fig. 1-6, the utility model provides an integral type test injection device, includingcasing 1 and locate its interiorfixed disk 2,injection module 3 andtest component 4,injection module 3 is fixed in on thefixed disk 2,injection module 3 side is located totest component 4, carries out the insulin injection throughinjection module 3 to the human body, andtest component 4 carries out blood sugar test to the human body.
Thecasing 1 is includingfirst cavity 11 andsecond cavity 12,injection subassembly 3 and fixeddisk 2 have been placed tofirst cavity 11,test subassembly 4 has been placed tosecond cavity 12.
Thefirst cavity 11 comprises anupper cavity 111 and alower cavity 112, thepower tube 31 is placed in theupper cavity 111, thestorage tube 32 and theneedle piece 33 are placed in thelower cavity 112, and thefixed disc 2 is clamped between theupper cavity 111 and thelower cavity 112.
Thelower cavity 112 includes apush cover 1121 and alocking portion 1122, thepush cover 1121 is detachably mounted on thelocking portion 1122, and thestorage tube 32 is mounted in thelower cavity 112 by detaching thepush cover 1121. Thepush cover 1121 is a transparent cover, and the scales of the storage tube can be seen through thepush cover 1121.
Theupper cavity 111 comprises asliding groove 1111 and asliding button 1112, thesliding button 1112 is connected with thepower tube 31 and arranged in thesliding groove 1111, and thesliding button 1112 pushes thepower tube 31 to slide along thesliding groove 1111.
Adisplay window 121 and akey 122 are arranged on thesecond cavity 12, adisplay screen 45 is arranged below thedisplay window 121, thekey 122 is electrically connected with theinfrared emission laser 42, and the blood glucose concentration is watched through thedisplay window 121 and thekey 122 controls theinfrared emission laser 42 to work.
Thefixed plate 2 is provided with a round hole (not shown), the round hole fixes thepower tube 31 of theinjection component 3 in theupper cavity 111, and thestorage tube 32 is connected with thepower tube 31 through the round hole.
Theinjection assembly 3 comprises apower tube 31, astorage tube 32 and aneedle piece 33, thestorage tube 32 is installed below thepower tube 31, theneedle piece 33 is connected with thestorage tube 32, insulin is filled in thestorage tube 32, and the insulin is injected through thepower tube 31 and theneedle piece 33.
Thepower tube 31 comprises atop part 311, apiston rod 312 and apush key 313, thetop part 311 and thepush key 313 are respectively arranged at two ends of thepiston rod 312, thepush key 313 is fixedly connected with aslide button 1112, and thepush key 313 pushes thetop part 311 at the other end of thepiston rod 312 to slide under the movement of theslide button 1112, so as to perform an injection action.
Thestorage tube 32 comprises atube rack 321, arubber film 322, atube body 323 and a piston 324, therubber film 322 and the piston 324 are arranged at two ends of thetube body 323, therubber film 322 is connected with theneedle piece 33, the piston 324 is connected with thetop 311 of thepower tube 31, insulin is filled in thetube body 323,scales 3211 are arranged on thetube rack 321, and the amount of the injected insulin is controlled by observing thescales 3211.
Theneedle piece 33 comprises aneedle 331 and aneedle cap 332, wherein theneedle 331 is internally provided with a thread (not shown), and is rotatably connected with therubber film 322 through the thread, and theneedle 331 can be used by uncovering theneedle cap 332.
Thetesting component 4 comprises amicroprocessor 41, aninfrared emission laser 42, adetector 43, asignal regulating circuit 44 and adisplay screen 45 which are electrically connected with the microprocessor, wherein theinfrared emission laser 42 irradiates the skin of a human body and transmits signals to thedetector 43, thedetector 43 converts optical signals into electric signals and transmits the electric signals to thesignal regulating circuit 44 for amplification, filtering and shaping, and themicroprocessor 41 performs correlation operation on the blood sugar concentration of the human body and transmits the blood sugar concentration result of the human body to thedisplay screen 45. The detector is a TeSnHg photoconductive detector, the sensitive wavelength of the testing component is determined through a spectrum experiment, and the testing component is calculated through spectrum analysis and is weak in capability of penetrating through skin based on mid-infrared light, so that a laser is selected as a light source, a human finger is used as a detection part to construct a mathematical model, and the microprocessor adopts the following models: C8051F 005.
The method comprises the following steps:
1) when the pen point of the integrated test injection device is aligned with the finger of a human body, the key is pressed, 5 seconds are waited, the blood glucose concentration value appears in the display window, and when the blood glucose of the whole blood in the empty abdomen exceeds 11.1 millimole/liter (200 milligram/deciliter), the insulin secretion is little or lacking. Therefore, when the fasting blood sugar is obviously increased, the diabetes can be diagnosed without other examinations; when 1 hour is fed, the blood sugar is 6.7-9.4 millimoles/liter to be a normal value, the blood sugar exceeding 11.1mmol/L (200mg/dl) is hyperglycemia, which indicates that the insulin secretion is little or lacking, and the blood sugar is less than or equal to 7.8 millimoles/liter to be a normal value after 2 hours;
2) when the hyperglycemia is judged, the patient should inject insulin; opening a transparent push cover, checking the top position of the power pipe before installing the storage pipe, and manually pushing the top to the bottom of the power pipe if the top position is not reached, wherein the state shown in FIG. 4 shows that the top is not reached, and the top needs to be pushed into the power pipe until the top cannot be seen;
3) placing the tube filled with insulin into a tube frame, sterilizing the rubber membrane with alcohol cotton sheet, installing unused needle, and removing the needle cap;
4) then, evacuation is carried out, mainly air in the needle head is discharged, namely the sliding button is pushed to observe the scale of the tube body, and the piston is pushed to the position which is level with the insulin;
5) the needle head is upwards, the slide button is pushed to the bottom, a click is heard, at the moment, a drop of insulin must appear on the needle head, and if the drop of insulin does not appear, thestep 4 is required to be returned to carry out emptying action again;
6) resetting the push cover, inserting the needle head into the injection site, pushing the slide button to the bottom, hearing a click to indicate that the dose is completely injected into the subcutaneous tissue, and pulling out the needle after the dose is stopped for at least 6 seconds after the injection;
7) the push cover is opened again, the needle cap is sleeved on the needle head, and the needle head piece is taken down and thrown into a recycling garbage can, so that the injection is completed.
The above-mentioned embodiments only represent one embodiment of the present invention, and the description thereof is specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for those skilled in the art, without departing from the spirit of the present invention, several variations and modifications can be made, which are within the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the appended claims.